Apricus Biosciences, Inc. (Nasdaq:APRI) announced the planned, oral presentation of clinical efficacy and safety data for both of its lead products in sexual medicine -- Vitaros(R) for erectile dysfunction ("ED") and Femprox(R) for Female Sexual Arousal Disorder ("FSAD") -- at the Biennial Meeting of the African Society for Sexual Medicine ("ASSM"), taking place in Dakar, Senegal, from December 15 to December 17, 2011.

Read full article at: http://pennyomega.com/18927/stock-alerts/apri-rprx-clno-angn-stock-highlights-by-pennyomegacom/

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

********************************



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services and 4,000,000 shares of 144 restricted stocks from the company for management fee through end of June for Cleantech Transit, Inc. (CLNO.OB).